Your browser doesn't support javascript.
loading
Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis.
Jawhar, M; Schwaab, J; Schnittger, S; Meggendorfer, M; Pfirrmann, M; Sotlar, K; Horny, H-P; Metzgeroth, G; Kluger, S; Naumann, N; Haferlach, C; Haferlach, T; Valent, P; Hofmann, W-K; Fabarius, A; Cross, N C P; Reiter, A.
Afiliação
  • Jawhar M; Department of Hematology and Oncology, University Medical Centre Mannheim, Mannheim, Germany.
  • Schwaab J; Department of Hematology and Oncology, University Medical Centre Mannheim, Mannheim, Germany.
  • Schnittger S; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Meggendorfer M; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Pfirrmann M; Institute for Medical Informatics, Biometry and Epidemiology, Ludwig-Maximilians University, Munich, Germany.
  • Sotlar K; Institute of Pathology, Ludwig-Maximilians University, Munich, Germany.
  • Horny HP; Institute of Pathology, Ludwig-Maximilians University, Munich, Germany.
  • Metzgeroth G; Department of Hematology and Oncology, University Medical Centre Mannheim, Mannheim, Germany.
  • Kluger S; Department of Hematology and Oncology, University Medical Centre Mannheim, Mannheim, Germany.
  • Naumann N; Department of Hematology and Oncology, University Medical Centre Mannheim, Mannheim, Germany.
  • Haferlach C; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Valent P; Division of Hematology and Ludwig Boltzmann Cluster Oncology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
  • Hofmann WK; Department of Hematology and Oncology, University Medical Centre Mannheim, Mannheim, Germany.
  • Fabarius A; Department of Hematology and Oncology, University Medical Centre Mannheim, Mannheim, Germany.
  • Cross NC; Wessex Regional Genetics Laboratory, Salisbury, UK.
  • Reiter A; Faculty of Medicine, University of Southampton, Southampton, UK.
Leukemia ; 30(1): 136-43, 2016 Jan.
Article em En | MEDLINE | ID: mdl-26464169
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Ribonucleoproteínas / Proteínas Nucleares / Proteínas Proto-Oncogênicas c-kit / Mastocitose Sistêmica / Subunidade alfa 2 de Fator de Ligação ao Core / Mutação Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Ribonucleoproteínas / Proteínas Nucleares / Proteínas Proto-Oncogênicas c-kit / Mastocitose Sistêmica / Subunidade alfa 2 de Fator de Ligação ao Core / Mutação Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha